Project milestone Open Access

Identifying new ligands for the SARS-CoV-2 Macrodomain by Fragment Screening and Multi-temperature Crystallography

James S Fraser

Research group(s)
QBI Coronavirus Research Group Structural Biology Consortium

Macrodomain is a compelling target for SARS-CoV-2, but there are no inhibitors (or even starting points for inhibitors). The QCRG Structural Biology Consortium performed a crystallographic fragments screen, identifying a few small molecules to kick-start our work to develop an inhibitor. Our friends in the UK, Ivan Ahel’s lab and X-Chem, did something similar and found even more fragment starting points. We are releasing the data together!

This record (see README file) has the data available here: https://fraserlab.com/macrodomain/ and published here: https://pubmed.ncbi.nlm.nih.gov/33853786/ 

Files (632.7 MB)
Name Size
macrodomain.zip
md5:7e114a9038057f2ced57ecdabb1a769a
1.6 MB Download
ucsf_nsp3_mac1_C2.zip
md5:5b53f87e16588241f36f2e53414a8d80
631.1 MB Download
1,602
259
views
downloads
All versions This version
Views 1,602708
Downloads 25940
Data volume 44.0 GB8.9 GB
Unique views 1,435618
Unique downloads 10833

Share

Cite as